MBA Simmons College USA
Research Associate, Harvard Business School
MIT Sloan School of Management
Extensive experience in licensing and intellectual property management
From 2001, Clarissa nvestigated topics related to the biotech industry, i.e. the relationships with biotech companies and pharmas, the economic environment that promotes the growth of the life science industry, and the development of orphan drugs.
In 2004 she joned Abcam, a UK company selling antibodies for research, as its first Marketing Manager North America. At Abcam she grew sales in the USA, preparing marketing materials, planning conferences and tradeshows, and talking to clients to understand their needs. She was promoted to Marketing Manager America, being responsible for identifying and training distributors in South America, China, and Korea.
In 2007 she moved to Philadelphia where she worked in technology transfer at the University of Pennsylvania and then The Fox Chase Cancer Center with Kurt Schwinghammer. She managed a portfolio of technologies from 36 investigators and physicians and was in charge of evaluating new inventions, licensing both technologies and tangible research materials (antibodies, cell lines, transgenic mice). She has negotiated license agreements, tangible research material agreements, industry-sponsored research agreements, and option agreements.
At the end of 2016, after 20 years of living in the US, she returned to Italy and joined the Bioindustry Park, Ivrea, Torino, as its Head of Technology Transfer. In this role, she evaluates new inventions from the University of Torino and from small enterprises, she assists in the patenting process and if necessary in the licensing process. She has also performed valuation of patents and technologies, market research, patentability opinions, and scouting activities.
Since May 2018 she is a consultant for different organizations (Bugnion a patent law firm based in Milano, and Pharma Quality Europe a consulting company based in Reggello, Firenze) where she performs technology evaluation and valuation, market research, scouting, activities of licensing (in and out), and patentability opinions.
Her major goal in every position she has held is to learn something new and to stretch her comfort zone. Her latest topic of interest these days is the valuation of a patent covering a potential drug, and the valuation of a small company.